Schering - Topic profile

HERE IS SOME POISTIVE NEWS FOR A CHANGE ABOUT SCHERING-PLOUGH... Replenishing The Pipeline: And The Winner Is… Company 2007 2012 Percent Change Schering-Plough 0.38 1.58 315.8% Amgen 4.50 1.46 -67.6% Bristol-Myers Squibb 1.08 0.84 -21.7% Wyeth 0.60 0.49 -18.2% Abbott Labs 1.73 0.42 -75.7% Johnson & Johnson 0.39 0.38 -2.4% GlaxoSmithKline 0.27 0.32 17.3% ...

We have added new boards for: BMS IT BiogenIdec IT Elan Endo IT Jazz Pharmaceuticals IT Medimmune IT Quest Diagnostics IT SGP IT Watson IT Please follow this link for the IT boards category: http://www.cafepharma.com/boards/forumdisplay.php? f=429

Zetia Zetia (Ezetimibe) is used for treating high blood cholesterol along with a low-fat, low-cholesterol diet.[b] Drug Uses Zetia treats high blood cholesterol along with a low-fat, low-cholesterol diet. It is also used to treat high blood sitosterol and campesterol along with diet therapy >>> Buy zetia online Cheap online zetia Zetia for cheap Zetia discount online pharmacy...

I think he was in charge of the Integrelin franchise.

Schering-Plough said regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts. More...

  Recs: 1 FDA unexpectedly rejects Schering anesthesia drug http://www.cnbc.com/id/25966557/for/cnbc By Ransdell Pierson updated 11:36 a.m. ET, Fri., Aug. 1, 2008 NEW YORK - Schering-Plough Corp said on Friday U.S. regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts and was ...

Schering-Plough said regulators had rejected Bridion, its drug to reverse the effects of anesthesia that had been heralded as a breakthrough product by analysts. More...

  Recs: 2 FDA unexpectedly rejects Schering anesthesia drug http://www.cnbc.com/id/25966567/for/cnbc /

  Recs: 4 Projected pipeline changes for major drug companies Replenishing The Pipeline: And The Winner Is… 14 Comments By Ed Silverman //  August 18th, 2008  // 2:40 pm Company 2007 2012 Percent Change Schering-Plough 0.38 1.58 315.8% Amgen 4.50 1.46 -67.6% Bristol-Myers Squibb 1.08 0.84 -21.7% Wyeth 0.60 0.49 -18.2% Abbott Labs 1....

Paul, Find us all jobs! CCG Field Force

I have the exact same ones as the first pic from Pakistan, Was it ever confirmed it was fake?

SP has hit the bottom of the gene pool and started digging. Did you boys get the roof fixed on the double wide fixsed wiff those in cent tave checks. Fred should get rid of all you, you are pathetic bunch of whiners

  Recs: 0 IMS Health: World Pharmaceutical Market Summary World Pharmaceutical Market Summary You have subscribed to the latest update on the world pharmaceutical market from IMS Health. In this month’s feature, we explore the hot topic of ‘21st Century Pharma: ...

  Recs: 0 from Yahoo board - basic info on EPIX Re: Results of trials 16-Aug-08 11:12 am med1..The two cognitive agents being studied by EPIX are quite different. 3140 is a novel 5-HT4 small molecule serotonin agonist specifically for AD...7034 is also a GPCR but works on a different site called 5-HT6...this compound also shows cognitive improvement but also seems to...

  Recs: 0 Replenishing The Pipeline: And The Winner Is… Replenishing The Pipeline: And The Winner Is… By Ed Silverman // August 18th, 2008 // 2:40 pm Company 2007 2012 Percent Change Schering-Plough 0.38 1.58 315.8% Amgen 4.50 1.46 -67.6% Bristol-Myers Squibb 1.08 0.84 -21.7% Wyeth 0.60 0.49 -18.2% Abbott Labs 1.73 0.42 -75.7% Johnson & Johnson 0.39 0...

  Recs: 0 Projected pipeline changes for major drug companies Replenishing The Pipeline: And The Winner Is… 14 Comments By Ed Silverman //  August 18th, 2008  // 2:40 pm Company 2007 2012 Percent Change Schering-Plough 0.38 1.58 315.8% Amgen 4.50 1.46 -67.6% Bristol-Myers Squibb 1.08 0.84 -21.7% Wyeth 0.60 0.49 -18.2% Abbott Labs 1....